Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

[Covalently conjugated DNA aptamer with doxorubicin as in vitro model for effective targeted drug delivery to human glioblastoma tumor cells].

Autor: Sliman YA; Burdenko Neurosurgical Center, Moscow, Russia.; Moscow Institute of Physics and Technology (National Research University), Dolgoprudny, Russia., Samoylenkova NS; Burdenko Neurosurgical Center, Moscow, Russia., Antipova OM; Lomonosov Moscow State University, Moscow, Russia., Brylev VA; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia., Veryutin DA; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia., Sapozhnikova KA; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia., Alekseeva AI; Avtsyn Research Institute of Human Morphology of federal state budgetary scientific institution «Petrovsky national research centre of surgery», Moscow, Russia.; Institute of Higher Nervous Activity and Neurophysiology, Moscow, Russia., Pronin IN; Burdenko Neurosurgical Center, Moscow, Russia., Kopylov AM; Lomonosov Moscow State University, Moscow, Russia., Pavlova GV; Burdenko Neurosurgical Center, Moscow, Russia.; Institute of Higher Nervous Activity and Neurophysiology, Moscow, Russia.; Sechenov First Moscow State Medical University, Moscow, Russia.

Publikováno v: Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko [Zh Vopr Neirokhir Im N N Burdenko] 2024; Vol. 88 (1), pp. 48-55.